These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 16612622
1. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Kyzas PA, Agnantis NJ, Stefanou D. Virchows Arch; 2006 Jun; 448(6):768-75. PubMed ID: 16612622 [Abstract] [Full Text] [Related]
3. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue. Eshghyar N, Mohammadi N, Rahrotaban S, Motahhary P, Vahedi Vaez SM. Arch Iran Med; 2011 Jul; 14(4):276-80. PubMed ID: 21726105 [Abstract] [Full Text] [Related]
4. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma. Zvrko E, Mikic A, Vuckovic L, Djukic V, Knezevic M. Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216 [Abstract] [Full Text] [Related]
5. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma. Marioni G, Marino F, Giacomelli L, Staffieri C, Mariuzzi ML, Violino E, De Filippis C. Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449 [Abstract] [Full Text] [Related]
6. Microvessel density in head and neck squamous cell carcinoma. Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A. Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1845-1851. PubMed ID: 29748768 [Abstract] [Full Text] [Related]
7. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma. Sakurai T, Okumura H, Matsumoto M, Uchikado Y, Owaki T, Kita Y, Setoyama T, Omoto I, Kijima Y, Ishigami S, Natsugoe S. Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351 [Abstract] [Full Text] [Related]
9. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q, Zhang B, Peng P. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [Abstract] [Full Text] [Related]
10. Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105. Marioni G, Nucci R, Marino F, Giacomelli L, Rugge M, Pareschi R, Martini A. Otol Neurotol; 2012 Jul; 33(5):843-8. PubMed ID: 22643443 [Abstract] [Full Text] [Related]
11. The EGFR-mTOR pathway and laryngeal cancer angiogenesis. Lionello M, Lovato A, Staffieri A, Blandamura S, Turato C, Giacomelli L, Staffieri C, Marioni G. Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188 [Abstract] [Full Text] [Related]
12. [The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance]. Liu Y, Xue X, Wang F. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):100-3. PubMed ID: 18476626 [Abstract] [Full Text] [Related]
13. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma. Marioni G, D'Alessandro E, Giacomelli L, Staffieri A. J Oral Pathol Med; 2010 May; 39(5):361-7. PubMed ID: 20537053 [Abstract] [Full Text] [Related]
14. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma. Zvrko E, Mikic A, Vuckovic L. Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039 [Abstract] [Full Text] [Related]
15. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA. APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267 [Abstract] [Full Text] [Related]
16. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma]. Bodnar M, Szylberg Ł, Kaźmierczak W, Marszałek A. Przegl Lek; 2012 Nov; 69(10):726-30. PubMed ID: 23421020 [Abstract] [Full Text] [Related]
17. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. Marioni G, Ottaviano G, Giacomelli L, Staffieri C, Casarotti-Todeschini S, Bonandini E, Staffieri A, Blandamura S. Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866 [Abstract] [Full Text] [Related]
18. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma. Marioni G, Staffieri A, Manzato E, Ralli G, Lionello M, Giacomelli L, Prosenikliev V, Marchese-Ragona R, Busnardo A, Bolzetta F, Blandamura S. Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405 [Abstract] [Full Text] [Related]
20. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Yao Y, Kubota T, Takeuchi H, Sato K. Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]